Aclarion, Inc. (NASDAQ:ACONW) Sees Significant Decrease in Short Interest

Aclarion, Inc. (NASDAQ:ACONW – Get Free Report) was the recipient of a large decline in short interest during the month of April. As of April 30th, there was short interest totaling 100 shares, a decline of 65.8% from the April 15th total of 292 shares. Based on an average daily volume of 7,518 shares, the days-to-cover ratio is currently 0.0 days.

Aclarion Price Performance

ACONW stock opened at $0.03 on Thursday. Aclarion has a 1-year low of $0.02 and a 1-year high of $0.23. The business’s 50 day simple moving average is $0.04 and its 200 day simple moving average is $0.04.

Get Aclarion alerts:

About Aclarion

(Get Free Report)

Aclarion, Inc, a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc and changed its name to Aclarion, Inc in December 2021.

Further Reading

• Five stocks we like better than Aclarion
• Airplane Maintenance Companies That Keep Flights Moving Are Ready to Soar
• Oklo Stock Could Be Ready for Another Massive Run
• D-Wave Earnings Looked Weak, But Investors May Be Missing This
• Nebius Upside Expands as AI Feedback Loop Intensifies

Receive News & Ratings for Aclarion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aclarion and related companies with MarketBeat.com's FREE daily email newsletter.